Bayer has filed for approval in the US for elinzanetant as a non-hormonal treatment for menopausal symptoms such as hot flushes, with a rival therapy from Astellas in its sights. The FDA ...

REUTERS/Tingshu Wang/File Photo Chinese battery maker CATL is set to price its shares at HK$263 ($33.70) each and increase the size of the company's Hong Kong listing, according to two sources ...

More than 13 lakh students are currently pursuing higher studies abroad. According to the data released by the MEA recently, 13,35,878 students were pursuing higher education in countries outside ...